Gerard Brophy
CIK 1776107 · EVP, Biopharma Production · last filed 2023-05-19
Gerard Brophy is an EVP, Biopharma Production who has filed 27 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider had shares withheld for taxes covering $399.2K of AVTR on May 19, 2023. Across all open-market trades the lifetime net is −$22.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $836.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$836.0K
2
27
-$22.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTR | EVP, Biopharma Production | 89,032 | $9.39 | $836.0K | -$1.07M | 9 | 2023-05-19 |
| Avantor, Inc. (AVTRpA) Delisted | EVP, Biopharma Production | 136,221 | $90.81 | $12.37M | -$21.12M | 18 | 2022-03-02 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-19 | AVTR | Tax (F) | −19,683 | -$399.2K | EDGAR |
| 2023-03-06 | AVTR | Sell (S) | −3,914 | -$97.8K | EDGAR |
| 2023-03-01 | AVTR | Sell (S) | −3,059 | -$76.5K | EDGAR |
| 2023-02-27 | AVTR | Mixed | +16,375 | -$96.8K | EDGAR |
| 2023-02-22 | AVTR | Tax (F) | −3,072 | -$75.4K | EDGAR |
| 2023-02-02 | AVTR | Mixed | +12,177 | -$647.9K | EDGAR |
| 2023-01-04 | AVTR | Tax (F) | −6,727 | -$141.9K | EDGAR |
| 2022-05-23 | AVTR | Sell (S) | −19,603 | -$613.0K | EDGAR |
| 2022-05-19 | AVTR | Tax (F) | −19,683 | -$616.7K | EDGAR |
| 2022-03-02 | Avantor, Inc. (AVTRpA) Delisted | Sell (S) | −2,027 | -$69.9K | EDGAR |